ITIF：自2027年起列入药物清单以确定价格的评论报告（英文版）

ITIF submits the following comments to the Centers for Medicare & Medicaid Services (CMS) in response to its request for public comment on the next 15 drugs to become subject to government price setting as part of the Inflation Reduction Act.1 In August 2022, the Biden administration signed into law the Inflation Reduction Act (IRA), the first law in American history to grant the Centers for Medicare & Medicaid Services (CMS) the authority to control the prices of drugs. Specifically,